- Home
- NVAX vs LX Comparison
NVAX vs LX Comparison
Compare NVAX & LX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- LX
- Stock Information
- Founded
- NVAX 1987
- LX 2013
- Country
- NVAX United States
- LX China
- Employees
- NVAX N/A
- LX N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- LX Finance: Consumer Services
- Sector
- NVAX Health Care
- LX Finance
- Exchange
- NVAX Nasdaq
- LX Nasdaq
- Market Cap
- NVAX 1.3B
- LX 1.3B
- IPO Year
- NVAX 1995
- LX 2017
- Fundamental
- Price
- NVAX $7.34
- LX $7.25
- Analyst Decision
- NVAX Buy
- LX
- Analyst Count
- NVAX 5
- LX 0
- Target Price
- NVAX $19.00
- LX N/A
- AVG Volume (30 Days)
- NVAX 14.2M
- LX 2.5M
- Earning Date
- NVAX 05-08-2025
- LX 05-21-2025
- Dividend Yield
- NVAX N/A
- LX 2.51%
- EPS Growth
- NVAX N/A
- LX 35.86
- EPS
- NVAX 2.97
- LX 1.07
- Revenue
- NVAX $1,254,962,000.00
- LX $1,938,367,396.00
- Revenue This Year
- NVAX $40.01
- LX $9.24
- Revenue Next Year
- NVAX N/A
- LX $6.03
- P/E Ratio
- NVAX $2.47
- LX $6.80
- Revenue Growth
- NVAX 25.92
- LX 5.63
- 52 Week Low
- NVAX $5.01
- LX $1.57
- 52 Week High
- NVAX $23.86
- LX $11.64
- Technical
- Relative Strength Index (RSI)
- NVAX 55.86
- LX 38.09
- Support Level
- NVAX $6.84
- LX $7.16
- Resistance Level
- NVAX $7.62
- LX $7.45
- Average True Range (ATR)
- NVAX 0.55
- LX 0.48
- MACD
- NVAX 0.07
- LX -0.15
- Stochastic Oscillator
- NVAX 50.52
- LX 13.40
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About LX LexinFintech Holdings Ltd.
LexinFintech Holdings Ltd is an online consumer finance platform and a technology-driven service provider in China. The group is engaged in online direct sales services and online consumer finance services for its customers in the PRC. Geographically, it derives revenue from China.